Given that Mfn2 defect contributes to metabolic defects associated with obesity, neuropathy, as well as cardiac dysfunction[23,37,38], it is understandable that Mfn2-deficiency leads to the inhibition of cell proliferation. This evidence concerns the gene MFN2 and neuropathy.